ClinicalTrials.Veeva

Menu

Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate. (TETHER)

C

Catholic University (KU) of Leuven

Status

Enrolling

Conditions

Randomized Controlled Trial
Hyaluronan-EnRiched Medium

Treatments

Other: use of hyaluronan-enriched transfer medium

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Assessing whether the use of hyaluronan-enriched transfer medium can increase the cumulative ongoing pregnancy rate

Enrollment

400 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with own oocytes/embryos;
  • Patients with female age at 1st OR in the study <40 year;
  • Patients planned for a 2nd oocyte retrieval, with no clinical ongoing pregnancy after the previous oocyte retrieval
  • Patients planned for a 3rd oocyte retrieval with no clinical ongoing pregnancy after previous oocyte retrievals
  • Patients with female age at 1st OR in the study <40 year;
  • Patients with BMI ≤32;
  • Patients with written informed consent;

Exclusion criteria

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

400 participants in 2 patient groups

study group
Active Comparator group
Description:
Patients receiving an embryo transfer in hyaluronan-enriched transfer medium
Treatment:
Other: use of hyaluronan-enriched transfer medium
control group
No Intervention group
Description:
Patients receiving an embryo transfer in conventional culture medium

Trial contacts and locations

1

Loading...

Central trial contact

Sophie Debrock, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems